US equities |
INTC $66.15 ▼-28.16% AMZN $241.15 ▼-1.08% MU $890.26 ▼-4.71% NVDA $206.44 ▼-3.38% GOOGL $282.30 ▼-0.54% SNDK $1,189.60 ▼-10.56% SPCX $138.25 ▼-3.92% AMD $513.51 ▼-9.34%
FinancialContent

ZyVersa Therapeutics, Inc. - Common Stock (NQ:ZVSA)

0.3113 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ZyVersa Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
ZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on Benzinga All Access
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
Why ZyVersa Therapeutics Shares Are Down 40% ↗
ZyVersa Therapeutics Inc (NASDAQ: ZVSA) shares are trading lower by 43.7% to $1.20 Thursday morning. 
Via Benzinga
News headline image
ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
This Biotech Is Targeting Indications Worth $70 Billion ↗
Stephen C. Glover, Co-founder, Chairman, CEO and President of ZyVersa Therapeutics Inc. (NASDAQ: ZVSA) was recently a guest on Benzinga’s All-Access. 
Via Benzinga
News headline image
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... 
Via Benzinga
News headline image
Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket ↗
Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering. Motus GI Holdings shares dipped 46.5% to $1.15 in... 
Via Benzinga
News headline image
ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2024”
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
ZyVersa Therapeutics Engages CRO, George Clinical, for Phase 2a Clinical Trial for Cholesterol Efflux Mediator VAR 200
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
Dow Surges 100 Points; Ciena Posts Upbeat Earnings ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Thursday. The Dow traded up 0.28% to 36,155 while the NASDAQ rose 1.41% to 14,346.47. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings. 
Via Benzinga
News headline image
Gold Moves Lower; Dollar General Earnings Beat Estimates ↗
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.06% to 36,077.32 while the NASDAQ rose 1.09% to 14,301.04.... 
Via Benzinga
Topics Earnings Stocks
News headline image
ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate with Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
Nasdaq Jumps Over 100 Points; US Jobless Claims Edge Higher ↗
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.04% to 36,068.53 while the... 
Via Benzinga
Topics Stocks
News headline image
Rivian (RIVN) Stock Just Scored a New ‘Buy’ Rating ↗
Rivian stock is gaining on Thursday after Stifel weighed in on RIVN shares with a buy rating and set a price target of $25 per share. 
Via InvestorPlace
News headline image
Why Is ZyVersa Therapeutics (ZVSA) Stock Down 44% Today? ↗
ZyVersa Therapeutics stock is falling hard on Thursday after the company priced a public offering for shares of ZVSA this morning. 
Via InvestorPlace
News headline image
Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! 
Via InvestorPlace
News headline image
ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
Shopify (SHOP) Stock Falls Following Analyst Downgrade ↗
Shopify stock is taking a beating on Wednesday after shares of SHOP were hit with a downgrade from Wedbush analyst Scott Devitt. 
Via InvestorPlace
News headline image
Why Is Pharvaris (PHVS) Stock Up 36% Today? ↗
Pharvaris stock is rising higher on Wednesday following news of an underwritten offering for PHVS shares and pre-funded warrants. 
Via InvestorPlace
News headline image
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 27% Today? ↗
ZyVersa Therapeutics stock is rising with heavy trading of ZVSA shares after a paper was published in a peer-reviewed journal. 
Via InvestorPlace
News headline image
ZyVersa Therapeutics Announces Publication Showing AIM2 and NLRP3 Inflammasomes Promote Atherosclerosis in Diabetes, Supporting IC 100’s Rationale for Targeting ASC to Inhibit Multiple Inflammasome Pathways
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
ZyVersa Therapeutics, Inc. Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
ZyVersa Therapeutics Reports Third Quarter 2023 Corporate Update and Financial Results
From ZyVersa Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >